Inhibitors of gastric acid secretion increase the risk of prion infection in mice

References

• Prusiner SB. Shattuck lecture–neurodegenerative diseases and prions. N Engl J Med 2001;344:1516–26.
   PubMed Web of Science ®Google Scholar
• Chesebro B. Human TSE disease–viral or protein only? Nat Med 1997;3:491–2.
   PubMedGoogle Scholar
• Taylor DM. Inactivation of prions by physical and chemical means. J Hosp Infect 1999;43:S69–76.
   PubMed Web of Science ®Google Scholar
• Murdoch H, Taylor D, Dickinson J, Walker JT, Perrett D, Raven ND, Surface decontamination of surgical instruments: an ongoing dilemma. J Hosp Infect 2006;63:432–8.
   PubMed Web of Science ®Google Scholar
• Lefrere JJ, Hewitt P. From mad cows to sensible blood transfusion: the risk of prion transmission by labile blood components in the United Kingdom and in France. Transfusion 2009;49:797–812.
   PubMed Web of Science ®Google Scholar
• Brown P, Preece M, Brandel JP, Sato T, McShane L, Zerr I, Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology 2000;55:1075–81.
   PubMed Web of Science ®Google Scholar
• Weissmann C, Enari M, Klohn PC, Rossi D, Flechsig E. Transmission of prions. Proc Natl Acad Sci U S A 2002;99:16378–83.
   PubMed Web of Science ®Google Scholar
• Hill AF, Desbruslais M, Joiner S, Sidle KCL, Gowland I, Collinge J, The same prion strain causes vCJD and BSE. Nature 1997;389:448–50.
   PubMed Web of Science ®Google Scholar
• Bruce ME, Will RG, Ironside JW, McConnell I, Drummond D, Suttie A, Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent. Nature 1997;389:498–501.
   PubMed Web of Science ®Google Scholar
• Gajdusek DC. Unconventional viruses and the origin and disappearance of kuru. Science 1977;197:943–60.
   PubMed Web of Science ®Google Scholar
• Shmakov AN, Ghosh S. Prion proteins and the gut: une liaison dangereuse? Gut 2001;48:443–7.
   PubMed Web of Science ®Google Scholar
• Aguzzi A. Neuro-immune connection in spread of prions in the body? Lancet 1997;349:742–3.
   PubMedGoogle Scholar
• Johnsen AH. Phylogeny of the cholecystokinin/gastrin family. Front Neuroendocrinol 1998;19:73–99.
   PubMed Web of Science ®Google Scholar
• Waldum HL, Sandvik AK, Brenna E, Petersen H. Gastrin-histamine sequence in the regulation of gastric acid secretion. Gut 1991;32:698–701.
   PubMed Web of Science ®Google Scholar
• Walsh JH, Richardson CT, Fordtran JS. pH dependence of acid secretion and gastrin release in normal and ulcer subjects. J Clin Invest 1975;55:462–8.
   PubMed Web of Science ®Google Scholar
• Wildersmith CH, Spirig C, Krech T, Merki HS. Bactericidal factors in gastric-juice. Eur J Gastroenterol Hepatol 1992;4:885–91.
   Google Scholar
• Martinsen TC, Bergh K, Waldum HL. Gastric juice: A barrier against infectious diseases. Basic Clin Pharmacol Toxicol 2005;96:94–102.
   PubMed Web of Science ®Google Scholar
• Mould DL, Dawson AM, Smith W. Scrapie in mice. The stability of the agent to various suspending media, ph and solvent extraction. Res Vet Sci 1965;6:151–4.
   PubMedGoogle Scholar
• Prusiner SB, Groth DF, McKinley MP, Cochran SP, Bowman KA, Kasper KC. Thiocyanate and hydroxyl ions inactivate the scrapie agent. Proc Natl Acad Sci U S A 1981;78:4606–10.
   PubMedGoogle Scholar
• Brown P, Rohwer RG, Gajdusek DC. Newer data on the inactivation of scrapie virus or Creutzfeldt-Jakob disease virus in brain tissue. J Infect Dis 1986;153:1145–8.
   PubMed Web of Science ®Google Scholar
• Appel TR, Lucassen R, Groschup MH, Joncic M, Beekes M, Riesner D. Acid inactivation of prions: efficient at elevated temperature or high acid concentration. J Gen Virol 2006;87:1385–94.
   PubMedGoogle Scholar
• Jeffrey M, Gonzalez L, Espenes A, Press CM, Martin S, Chaplin M, Transportation of prion protein across the intestinal mucosa of scrapie-susceptible and scrapie-resistant sheep. J Pathol 2006;209:4–14.
   PubMed Web of Science ®Google Scholar
• Martinsen TC, Taylor DM, Johnsen R, Waldum HL. Gastric acidity protects mice against prion infection? Scand J Gastroenterol 2002;37:497–500.
   PubMed Web of Science ®Google Scholar
• Le Dur A, Beringue V, Andreoletti O, Reine F, Lai TL, Baron T, A newly identified type of scrapie agent can naturally infect sheep with resistant PrP genotypes. Proc Natl Acad Sci U S A 2005;102:16031–6.
   PubMed Web of Science ®Google Scholar
• Waldum HL, Brenna E, Martinsen TC. Safety of proton pump inhibitors. Aliment Pharmacol Ther 2000;14:1537–8.
   PubMed Web of Science ®Google Scholar
• Kimberlin RH, Walker CA. Pathogenesis of scrapie (strain 263K) in hamsters infected intracerebrally, intraperitoneally or intraocularly. J Gen Virol 1986;67:255–63.
   PubMed Web of Science ®Google Scholar
• Gale P. The infectivity of transmissible spongiform encephalopathy agent at low doses: the importance of phospholipid. J Appl Microbiol 2006;101:261–74.
   PubMedGoogle Scholar
• Graham DY, Alpert LC, Smith JL, Yoshimura HH. Iatrogenic Campylobacter pylori infection is a cause of epidemic achlorhydria. Am J Gastroenterol 1988;83:974–80.
   PubMed Web of Science ®Google Scholar
• Hatlebakk JG, Hyggen A, Madsen PH, Walle PO, Schulz T, Mowinckel P, Heartburn, treatment in primary care: randomised, double blind study for 8 weeks. Br Med J 1999;319:550–3.
   PubMed Web of Science ®Google Scholar
• Taylor D. Resistance of transmissible spongiform encephalopathy agents to decontamination. In: Rabenau H, Cinatl J, Doerr H, editors. Prions A challange for science. Basel: Karger; 2001. pp. 58–67.
   Google Scholar
• Benestad SL, Sarradin P, Thu B, Schonheit J, Tranulis MA, Bratberg B. Cases of scrapie with unusual features in Norway and designation of a new type, Nor98. Vet Rec 2003;153:202–8.
   PubMed Web of Science ®Google Scholar